Sentinel lymph node biopsy in the management of breast cancer

Indian Journal of Cancer

Volumn 40, Issue 2, 2003, Pages 60-66

  Kumar, R ^a   Bozkurt, M F ^a   Zhuang, H ^a   Alavi, A ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Blue dye; Breast cancer; Neoadjuvant chemotherapy; Radio colloid; Sentinel node biopsy

Indexed keywords

AXILLA; BREAST; BREAST CANCER; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER STAGING; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; FROZEN SECTION; HUMAN; INTERMETHOD COMPARISON; LYMPHATIC SYSTEM; REVIEW; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; BREAST TUMOR; FEMALE; METASTASIS; METHODOLOGY; PATHOLOGY;

BREAST NEOPLASMS; FEMALE; HUMANS; NEOPLASM METASTASIS; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY;

EID: 1342327540     PISSN: 0019509X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 1999;49:8-31.
2. Wingo PA, Cardinez CJ, Landis SH, Greenlee RT, Ries LA, Anderson RN, et al. Long-term trends in cancer mortality in the United States, 1930-1998. Cancer 2003;97:3133-75.
3. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349:546-53.
4. Schrenk P, Rieger R, Shamiyeh A, Wayand W. Morbidity following Sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 2000;88: 608-14.
5. Peintinger F, Reitsamer R, Stranzl H, Ralph G. Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients. Br J Cancer 2003;89:648-52.
6. B Cady. The need to reexamine axillary lymph node dissection in invasive breast cancer [Editorial]. Cancer 1994;73:505-8.
7. Pandelidis SM, Peters KL, Walusimbi MS, Casady RL, Laux SV, Cavanaugh SH, et al. The role of axillary dissection in mammographically detected carcinoma. J Am Coll Surg 1997;184:341-5.
8. Morrow M, Foster RS Jr. Staging of breast cancer: a new rationale for internal mammary node biopsy. Arch Surg 1981;116: 748-51.
9. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977;39:456-66.
10. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-9.
11. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
12. Osborne MT. Breast development and anatomy. In: Harris JR, Morrow M, Lippman ME, Hellman S, editors. Diseases of the Breast. Cedar Knolls, NJ: Lippincott-Raven Healthcare; 1996. Vol 1. pp. 1-14.
13. Turner-Warwick RT. The lymphatics of the breast. Br J Surg 1959;46:574-82.
14. Wong SL, Edwards MJ, Chao C, Tuttle TM, Noyes RD, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate. J Am Coll Surg 2001;192:684-91.
15. McMasters KM, Wong SL, Tuttle TM, Carlson DJ, Brown CM, Dirk Noyes R, et al. Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes. Ann Surg 2000;231:724-31.
16. Cody HS III. Clinical aspects of sentinel node biopsy. Breast Cancer Res 2001;3:104-8.
17. Kumar R, Jana S, Heiba SI, Dakhel M, Axelrod D, Siegel B, et al. Retrospective analysis of sentinel node localization in multicentric palpable and non-palpable breast cancer. J Nucl Med 2003;44:7-10.
18. Uren RF, Howman-Giles RB, Thompson JF, Malouf D, Ramsey-Stewart G, Niesche FW, et al. Mammary lymphoscintigraphy in breast cancer. J Nucl Med 1995;36:1775-80.
19. Uren RF, Thompson JF, Howman-Giles R. Sentinel-lymph node biopsy in breast cancer. Lancet 1998;352:1472-3.
20. McMasters KM, Wong SL, Martin RC 2nd, Chao C, Tuttle TM, Noyes RD, et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multi-institutional study. Ann Surg. 2001;233: 676-87.
21. Pelosi E, Baiocco C, Ala A, Gay E, Bello M, Varetto T, et al, Lymphatic mapping in early stage breast cancer: comparison between periareolar and subdermal injection. Nucl Med Commun 2003;24: 519-23.
22. Celliers L, Mann GB. Alternative sites of injection for sentinel lymph node biopsy in breast cancer. ANZ J Surg 2003;73:600-4.
23. Kern KA, Rosenberg RJ. Preoperative lymphoscintigraphy during lymphatic mapping for breast cancer: improved sentinel node imaging using subareolar injection of technetium 99m sulfur colloid. J Am Coll Surg 2000;191:479-89.
24. Linehan DC, Hill AD, Tran KN, Yeung H, Yeh SD, Borgen PI, et al. Sentinel lymph node biopsy in breast cancer: unfiltered radioisotope is superior to filtered. J Am Coll Surg 1999;188:377-81.
25. De Cicco C, Cremonesi M, Luini A, Bartolomei M, Grana C, Prisco G, et al. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer. J Nucl Med 1998;39:2080-84.
26. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, et al. The sentinel node in breast cancer-a multicenter validation study. N Engl J Med 1998;33:941-6.
27. Victorzon M, Hamalainen E, Svartback M, Lantto A. Extra-axillary sentinel node biopsy in breast cancer staging-is it necessary? Eur J Surg Oncol 2003;29:604-6.
28. Upponi SS, McIntosh SA, Wishart GC, Balan KK, Purushotham AD. Sentinel lymph node biopsy in breast cancer-is lymphoscintigraphy really necessary? Eur J Surg Oncol 2002;28:479-80.
29. Rutgers EO, Nieweg OE. How to do it: the Netherlands Cancer Institute approach. In: Cody HS III, editor. Sentinel node biopsy. London, England: Martin Dunitz; 2002. pp. 245-9.
30. Cox CE, Bass SS, Boulware D, Ku NK, Berman C, Reintgen DS. Implementation of new surgical technology: outcome measures for lymphatic mapping of breast carcinoma. Ann Surg Oncol 1999;6:553-61.
31. Morrow M, Rademaker AW, Bethke KP, Talamonti MS, Dawes LG, Clauson J, et al. Learning sentinel node biopsy: results of a prospective randomized trial of two techniques. Surgery 1999;126: 714-20.
32. Cody HS 3rd, Hill AD, Tran KN, Brennan MF, Borgen PI. Credentialing for breast lymphatic mapping: how many cases are enough? Ann Surg 1999;229:723-6.
33. McMasters KM, Wong SL, Chao C, Woo C, Tuttle TM, Noyes RD, et al. Defining the optimal surgeon experience for breast cancer sentinel lymph node biopsy: a model for implementation of new surgical techniques. Ann Surg 2001;234:292-9.
34. Schwartz GF, Giuliano AE, Veronesi U. Consensus Conference Committee. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, Pennsylvania. Cancer 2002;94: 2542-51.
35. Fraile M, Rull M, Julian FJ, Fuste F, Barnadas A, Llatjos M, et al. Sentinel node biopsy as a practical alternative to axillary lymph node dissection in breast cancer patients: an approach to its validity. Ann Oncol 2000;11:701-5.
36. Shivers S, Cox C, Leight G, Beauchamp D, Blumencranz P, Ross M, et al. Final results of the Department of Defense multicenter breast lymphatic mapping trial. Ann Surg Oncol 2002;9:248-55.
37. Tafra L, Lannin DR, Swanson MS, Van Eyk JJ, Verbanac KM, Chua AN, et al. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg 2001;233:51-9.
38. Carter C, Allen C, Henson D. Relation of tumor size, lymph node status and survival in 24,740 breast cancer cases. Cancer 1989; 63:181-7.
39. Chung MH, Ye W, Giuliano AE. Role for sentinel lymph node dissection in the management of large (>or=5 cm) invasive breast cancer. Ann Surg Oncol 2001;8:688-92.
40. Wong SL, Chao C, Edwards MJ, Tuttle TM, Noyes RD, Carlson DJ, et al. Accuracy of sentinel lymph node biopsy for patients with T2 and T3 breast cancer. Am Surg 2001;67:522-6.
41. Bedrosian I, Reynolds C, Mick R, Callans LS, Grant CS, Donohue JH, et al. Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors. Cancer 2000;88:2540-5.
42. Breslin TM, Cohen L, Sahin A, Fleming JB, Kuerer HM, Newman LA, et al. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol 2000;18:3480-6.
43. Nason KS, Anderson BO, Byrd DR, Dunnwald LK, Eary JF, Mankoff DA, et al. Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. Cancer 2000;89:2187-94.
44. Cohen LF, Breslin TM, Kuerer HM, Ross MI, Hunt KK, Sahin AA. Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy. Am J Surg Pathol 2000;24:1266-72.
45. Haid A, Tausch C, Lang A, Lutz J, Fritzsche H, Peschina W, et al. Is sentinel lymph node biopsy reliable and indicated after preoperative chemotherapy in patients with breast carcinoma? Cancer 2001;92:1080-4.
46. Fernandez A, Cortes M, Benito E, Azpeitia D, Prieto L, Moreno A, et al. Gamma probe sentinel node localization and biopsy in breast cancer patients treated with a neoadjuvant chemotherapy scheme. Nucl Med Commun 2001;22:361-6.
47. Julian TB, Patel N, Dusi D, Olson P, Nathan G, Jasnosz K, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer. Am J Surg 2001;182:407-10.
48. Tafra L, Verbanac KM, Lannin DR. Preoperative chemotherapy and sentinel lymphadenectomy for breast cancer. Am J Surg 2001;182:312-5.
49. Stearns V, Ewing CA, Slack R, Penannen MF, Hayes DF, Tsangaris TN. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol 2002;9:235-42.
50. Miller AR, Thomason VE, Yeh IT, Alrahwan A, Sharkey FE, Stauffer J, et al. Analysis of sentinel lymph node mapping with immediate pathologic review in patients receiving preoperative chemotherapy for breast carcinoma. Ann Surg Oncol 2002;9:243-7.
51. Mamounas EP, Brown A, Smith R. Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: updated results from NSABP B-27. Proc Am Soc Clin Oncol 2002;21:140.
52. Julian TB, Dusi D, Wolmark N. Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer. Am J Surg 2002;184:315-7.
53. Brady EW. Sentinel lymph node mapping following neoadjuvant chemotherapy for breast cancer. Breast J 2002;8:97-100.
54. Piato JR, Barros AC, Pincerato KM, Sampaio AP, Pinotti JA. Sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy. A pilot study. Eur J Surg Oncol 2003;29:118-20.
55. Reitsamer R, Peintinger F, Rettenbacher L, Prokop E. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy. J Surg Oncol 2003;84:63-7.
56. Schwartz GF, Meltzer AJ. Accuracy of axillary sentinel lymph node biopsy following neoadjuvant (induction) chemotherapy for carcinoma of the breast. Breast J 2003;9:374-9.
57. Sabel MS, Schott AF, Kleer CG, Merajver S, Cimmino VM, Diehl KM, et al. Sentinel node biopsy prior to neoadjuvant chemotherapy. Am J Surg 2003;186:102-5.
58. Schrenk P, Hochreiner G, Fridrik M, Wayand W. Sentinel node biopsy performed before preoperative chemotherapy for axillary lymph node staging in breast cancer. Breast J 2003;9:282-7.
59. Mamounas EP. Sentinel lymph node biopsy after neoadjuvant systemic therapy. Surg Clin North Am 2003;83:931-42.
60. Schrenk P, Wayand W. Sentinel-node biopsy in axillary lymph-node staging for patients with multicentric breast cancer. Lancet 2001;357:122.
61. Fernandez K, Swanson M, Verbanac K, Tafra L. Is sentinel lymphadenectomy accurate in multifocal and multicentric breast cancer [abstract]. Ann Surg Oncol 2002;9:S16-7.
62. Dowlatshahi K, Fan M, Snider HC, Habib FA. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 1997;80:188-97.
63. Pargaonkar AS, Beissner RS, Snyder S, Speights VO Jr. Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer. Arch Pathol Lab Med 2003;127:701-5.
64. G Cserni. Complete sectioning of axillary sentinel nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients. J Clin. Pathol 2002;55:926-31.
65. Fisher CJ, Boyle S, Burke M, Price AB. Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance. Br J Surg 1993;80:457-8.
66. Creager AJ, Geisinger KR, Shiver SA, Perrier ND, Shen P, Ann Shaw J, et al. Intraoperative evaluations of sentinel lymph nodes for metastatic breast carcinoma by imprint cytology. Mod Pathol 2002;15:1140-7.
67. Efron P, Knudsen E, Hirshorn S, Copeland EM. Anaphylactic reaction to isosulfan blue used for sentinel node biopsy: case report and literature review. Breast J 2002;8:396-9.
68. Waddington WA, Keshtgar MR, Taylor I, Lakhani SR, Short MD, EII PJ. Radiation safety of the sentinel lymph node technique in breast cancer. Eur J Nucl Med 2000;27:377-91.
69. Miner TJ, Shriver CD, Flicek PR, Miner FC, Jaques DP, Maniscalco-Theberge ME, et al. Guidelines for the safe use of radioactive materials during localization and resection of the sentinel lymph node. Ann Surg Oncol 1999;6:75-82.
70. Cremonesi M, Ferrari M, Sacco E, Rossi A, De Cicco C, Leonardi L, et al. Radiation protection in radioguided surgery of breast cancer. Nucl Med Commun 1999;20:919-24.
71. Eshima D, Fauconnier T, Eshima L, Thornback JR. Radiopharmaceuticals for lymphoscintigraphy: including dosimetry and radiation considerations. Semin Nucl Med 2000;30:25-32.
72. Krontiras H, Bland KI. When is sentinel node biopsy for breast cancer contraindicated? Surg Oncol 2003;12:207-10.
73. Port ER, Fey J, Gemignani ML, Heerdt AS, Montgomery LL, Petrek JA, et al. Reoperative sentinel lymph node biopsy: a new option for patients with primary or locally recurrent breast carcinoma. J Am Coll Surg 2002;195:167-72. 66